Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial - David Erritzøe; Tommaso Barba; Kyle T. Greenway; Roberta Murphy; Jonny Martell; Bruna Giribaldi; Christopher Timmermann; Ashleigh Murphy-Beiner; Michelle Baker Jones; David Nutt; Brandon Weiss; Robin Carhart-Harris (EClinicalMedicine, 2024)
Exported from Psilocybin Research Publication Tracker: https://psilocybin-research.com